Retraction notice to “Si RNA inhibition of GRP58 associated with decrease in mitomycin C-induced DNA cross-linking and cytotoxicity”: [Chem. Biol. Interact. 162/1 (2006) 81–87](S0009279706001323)(10.1016/j.cbi.2006.05.009));Si RNA inhibition of GRP58 associated with decrease in mitomycin C-induced DNA cross-linking and cytotoxicity

Chemico-Biological Interactions

Volumn 162, Issue 1, 2006, Pages 81-87

  Su, Shibing ^a,b   Adikesavan, Anbu Karani ^a   Jaiswal, Anil K ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cytotoxicity; DNA cross linking; GRP58; Mitomycin C

Indexed keywords

CYSTEINE; DNA; GLUCOSE REGULATED PROTEIN; MITOMYCIN C; SMALL INTERFERING RNA; THIOREDOXIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COLON CARCINOMA; CONTROLLED STUDY; CYTOTOXICITY; DNA CROSS LINKING; HUMAN; HUMAN CELL; MUTAGENESIS; PROTEIN DOMAIN; PROTEIN FUNCTION;

EID: 33746035307     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2017.05.023     Document Type: Erratum

References (24)

1. Workman P. Enzyme-directed bioreductive drug development revisited: a commentary on recent progress and future prospects with emphasis on quinone anticancer agents and quinone metabolizing enzymes, particularly DT-diaphorase. Oncol. Res. 6 (1994) 461-475
2. Ross D., Siegel D., Beall H., Prakash A.S., Mulcahy T., and Gibson N. DT diaphorase in activation and detoxification of quinones. Cancer Metab. Rev. 12 (1993) 83-101
3. Verweij J., and Pinedo H.H. Mitomycin C in cancer chemotherapy and biological modifiers. In: Pinedo H.M., Cabner B.A., and Longo D.L. (Eds). Annual 11 (1990), Elsevier Science Publishers, Amsterdam 63-73
4. Siegel D., Beall H., Senekowitsch C., Kasai M., Arai H., Gibson N.W., and Ross D. Bioreductive activation of mitomycin C by DT diaphorase. Biochemistry 31 (1992) 7879-7885
5. Kumar G.S., Lipman R., Cummings J., and Thomaz M. Mitomycin C-DNA adducts generated by DT-diaphorase. Revised mechanism of enzymatic reductive activation of mitomycin C. Biochemistry 36 (1997) 14128-14136
6. Wang X., Doherty G.P., Leith M.K., Curphey T.J., and Begleiter A. Enhanced cytotoxicity of mitomycin C in human tumor cells with inducers of DT diaphorase. Br. J. Cancer 80 (1999) 1223-1230
7. Pan S.S., Andews P.A., Glover C.J., and Bachur N.R. Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH:cytochrome P-450 reductase and xanthine oxidase. J. Biol. Chem. 259 (1984) 959-966
8. Belcourtel M.F., Hodnick W.F., Rockwell S., and Sartorelli A.C. Differential toxicity of mitomycin C and porfiromycin to aerobic and hypoxic Chinese hamster ovary cells overexpressing human NADPHxytochrome c (P-450) reductase. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 456-460
9. Pritsos C.A., and Gustafson D.L. Xanthine dehydrogenase and its role in cancer chemotherapy. Oncol. Res. 6 (1994) 477-481
10. Siegel D., Gibson N.W., Perusch P.C., and Ross D. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells. Cancer Res. 50 (1990) 7293-7300
11. Joseph P., Xu Y., and Jaiswal A.K. Non-enzymatic and enzymatic activation of mitomycin C: identification of a unique cytosolic activity. Int. J. Cancer 65 (1996) 263-271
12. Joseph P., Xu Y., and Jaiswal A.K. A unique cytosolic activity related but distinct from NQO1 catalyzes metabolic activation of mitomycin C. Br. J. Cancer 82 (2000) 1305-1311
13. Antoniou A.N., Ford S., Alphey M., Osborne A., Elliot T., and Powis S.J. The oxidoreductase ERp57 efficiently reduces partially folded in preference to fully folded MHC class I molecules. EMBO J. 21 (2002) 2655-2663
14. Coppari S., Altieri F., Ferraro A., Chichiarelli S., Eufemi M., and Turano C. Nuclear localization and DNA interaction of protein disulfide isomerase ERp57 in mammalian cells. J. Cell. Biochem. 85 (2002) 325-333
15. Ferraro A., Altieri F., Coppari S., Eufemi M., Chichiarelli S., and Turano C. Binding of the protein disulfide isomerase isoform ERp60 to the nuclear matrix-associated regions of DNA. J. Cell. Biochem. 72 (1999) 528-539
16. Ndubuisi M.I., Guo G.G., Fried V.A., Etlinger J.D., and Sehgal P.B. Cellular physiology of STA3: where's the cytoplasmic monomer?. J. Biol. Chem. 274 (1999) 25499-25509
17. Celli C.M., and Jaiswal A.K. Role of GRP58 in mitomycin C-induced DNA cross-linking. Cancer Res. 63 (2003) 6016-6025
18. Jain A.K., Bloom D.A., and Jaiswal A.K. Nuclear import and export signals in control of Nrf2. J. Biol. Chem. 280 (2005) 29158-29168
19. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. J. Immunol. Meth. 89 (1986) 271-277
20. Joseph P., and Jaiswal A.K. NAD(P)H:quinone oxidoreductasel (DT diaphorase) specifically prevents the formation of benzo(a)pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8413-8417
21. Hirano N., Shibasaki F., Sakai R., Tanaka T., Nishida J., Yazaki Y., Takenawa T., and Hirai H. Molecular cloning of the human glucose-regulated protein ERp57/GRP58, a thiol-dependent reductase: identification of its secretory form and inducible expression by the oncogenic transformation. Eur. J. Biochem. 234 (1995) 336-342
22. Tomida A., and Tsuruo T. Drug resistance mediated by cellular stress response to the microenvironment of solid tumors. Anti-Cancer Drug Design 14 (1999) 169-177
23. Bourdi M., Demady D., Martin J.L., Jabbour S.K., Martin B.M., George J.W., and Pohl L.R. cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58: characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase. Arch. Biochem. Biophys. 323 (1995) 397-403
24. Briquet-Laugier V., Xia Y.R., Rooke K., Mehrabian M., Lusis A.J., and Doolittle M.H. Mapping of three members of the mouse protein disulfide isomerase family. Mammal. Genome 9 (1998) 176-177